|
1
|
Afkarian M, Sachs MC, Kestenbaum B, et al:
Kidney disease and increased mortality risk in type 2 diabetes. J
Am Soc Nephrol. 24:302–308. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Papa G, Degano C, Iurato MP, Licciardello
C, Maiorana R and Finocchiaro C: Macrovascular complication
phenotypes in type 2 diabetic patients. Cardiovasc Diabetol.
12:202013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ginter E and Simko V: Global prevalence
and future of diabetes mellitus. Adv Exp Med Biol. 771:35–41.
2012.PubMed/NCBI
|
|
4
|
Biasini E, Unterberger U, Solomon IH, et
al: A mutant prion protein sensitizes neurons to glutamate-induced
excitotoxicity. J Neurosci. 33:2408–2418. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Franks PW: Gene x environment interactions
in type 2 diabetes. Curr Diab Rep. 11:552–561. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wittmeier KD, Wicklow BA, Sellers EA,
Griffith AT, Dean HJ and McGavock JM: Success with lifestyle
monotherapy in youth with new-onset type 2 diabetes. Paediatr Child
Health. 17:129–132. 2012.PubMed/NCBI
|
|
7
|
Tobias DK, Hu FB, Chavarro J, Rosner B,
Mozaffarian D and Zhang C: Healthful dietary patterns and type 2
diabetes mellitus risk among women with a history of gestational
diabetes mellitus. Arch Intern Med. 172:1566–1572. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tentolouris N, Andrianakos A, Karanikolas
G, et al: Type 2 diabetes mellitus is associated with obesity,
smoking and low socioeconomic status in large and representative
samples of rural, urban, and suburban adult Greek populations.
Hormones (Athens). 11:458–467. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Drong AW, Lindgren CM and McCarthy MI: The
genetic and epigenetic basis of type 2 diabetes and obesity. Clin
Pharmacol Ther. 92:707–715. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Simmons RA: Programming of DNA methylation
in type 2 diabetes. Diabetologia. 56:947–948. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gilbert ER and Liu D: Epigenetics: the
missing link to understanding β-cell dysfunction in the
pathogenesis of type 2 diabetes. Epigenetics. 7:841–852. 2012.
|
|
12
|
Kirchner H, Osler ME, Krook A and Zierath
JR: Epigenetic flexibility in metabolic regulation: disease cause
and prevention? Trends Cell Biol. 23:203–209. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zeng Y, Gu P, Liu K and Huang P: Maternal
protein restriction in rats leads to reduced PGC-1α expression via
altered DNA methylation in skeletal muscle. Mol Med Rep. 7:306–312.
2013.PubMed/NCBI
|
|
14
|
Yang BT, Dayeh TA, Volkov PA, et al:
Increased DNA methylation and decreased expression of PDX-1 in
pancreatic islets from patients with type 2 diabetes. Mol
Endocrinol. 26:1203–1212. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu ZH, Chen LL, Deng XL, et al:
Methylation status of CpG sites in the MCP-1 promoter is correlated
to serum MCP-1 in type 2 diabetes. J Endocrinol Invest. 35:585–589.
2012.PubMed/NCBI
|
|
16
|
Yang M, Sun JZ, Sun YL, You W, Dai J and
Li GS: Association between leptin gene promoter methylation and
type 2 diabetes mellitus. Zhonghua Yi Xue Yi Chuan Xue Za Zhi.
29:474–477. 2012.(In Chinese).
|
|
17
|
Burdge GC, Hoile SP and Lillycrop KA:
Epigenetics: are there implications for personalised nutrition?
Curr Opin Clin Nutr Metab Care. 15:442–447. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu Y, Wang J, Khaled W, et al: Bcl11a is
essential for lymphoid development and negatively regulates p53. J
Exp Med. 209:2467–2483. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Uda M, Galanello R, Sanna S, et al:
Genome-wide association study shows BCL11A associated with
persistent fetal hemoglobin and amelioration of the phenotype of
beta-thalassemia. Proc Natl Acad Sci USA. 105:1620–1625. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ishii N, Wei M, Kakehashi A, et al:
Enhanced urinary bladder, liver and colon carcinogenesis in zucker
diabetic fatty rats in a multiorgan carcinogenesis bioassay:
Evidence for mechanisms involving activation of PI3K signaling and
impairment of p53 on urinary bladder carcinogenesis. J Toxicol
Pathol. 24:25–36. 2011. View Article : Google Scholar
|
|
21
|
Labie D: BCL11A controls the expression of
the human fetal hemoglobin. Med Sci (Paris). 28:923–925. 2012.(In
French).
|
|
22
|
Xu J, Bauer DE, Kerenyi MA, et al:
Corepressor-dependent silencing of fetal hemoglobin expression by
BCL11A. Proc Natl Acad Sci USA. 110:6518–6523. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pardini VC, Victória IM, Pieroni FB, et
al: Fetal hemoglobin levels are related to metabolic control in
diabetic subjects. Braz J Med Biol Res. 32:695–701. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Simonis-Bik AM, Nijpels G, van Haeften TW,
et al: Gene variants in the novel type 2 diabetes loci
CDC123/CAMK1D, THADA, ADAMTS9, BCL11A, and MTNR1B affect different
aspects of pancreatic beta-cell function. Diabetes. 59:293–301.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jonsson A, Ladenvall C, Ahluwalia TS, et
al: Effects of common genetic variants associated with type 2
diabetes and glycemic traits on α- and β-cell function and insulin
action in humans. Diabetes. 62:2978–2983. 2013.
|
|
26
|
Cauchi S, Ezzidi I, El Achhab Y, et al:
European genetic variants associated with type 2 diabetes in North
African Arabs. Diabetes Metab. 38:316–323. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Langberg KA, Ma L, Sharma NK, et al:
American Diabetes Association GENNID Study Group: Single nucleotide
polymorphisms in JAZF1 and BCL11A gene are nominally associated
with type 2 diabetes in African-American families from the GENNID
study. J Hum Genet. 57:57–61. 2012. View Article : Google Scholar
|
|
28
|
Definition and diagnosis of diabetes
mellitus and intermediate hyperglycemia: report of a WHO/IDF
consultation. World Health Organization; Geneva, Switzerland: pp.
212006
|
|
29
|
Lolekha PH, Srisawasdi P, Jearanaikoon P,
Wetprasit N, Sriwanthana B and Kroll MH: Performance of four
sources of cholesterol oxidase for serum cholesterol determination
by the enzymatic endpoint method. Clin Chim Acta. 339:135–145.
2004.PubMed/NCBI
|
|
30
|
Schumann G, Klauke R, Canalias F, et al:
IFCC primary reference procedures for the measurement of catalytic
activity concentrations of enzymes at 37°C. Part 9: reference
procedure for the measurement of catalytic concentration of
alkaline phosphatase International Federation of Clinical Chemistry
and Laboratory Medicine (IFCC) Scientific Division, Committee on
Reference Systems of Enzymes (C-RSE) (1)). Clin Chem Lab Med.
49:1439–1446. 2011.
|
|
31
|
Guo JA, Mo PS and Li GX: Immobilization of
glucose oxidase and peroxidase and their application in
flow-injection analysis for glucose in serum. Appl Biochem
Biotechnol. 23:15–24. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jiang D, Zheng D, Wang L, et al: Elevated
PLA2G7 gene promoter methylation as a gender-specific marker of
aging increases the risk of coronary heart disease in females. PLoS
One. 8:e597522013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Harada H, Miyamoto K, Yamashita Y, et al:
Methylation of breast cancer susceptibility gene 1 (BRCA1) predicts
recurrence in patients with curatively resected stage I non-small
cell lung cancer. Cancer. 119:792–798. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cheng J, Wang L, Xu L, et al:
Gender-dependent miR-375 promoter methylation and the risk of type
2 diabetes. Exp Ther Med. 5:1687–1692. 2013.PubMed/NCBI
|
|
35
|
Legato MJ, Gelzer A, Goland R, et al;
Writing Group for The Partnership for Gender-Specific Medicine.
Gender-specific care of the patient with diabetes: review and
recommendations. Gend Med. 3:131–158. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Huxley R, Barzi F and Woodward M: Excess
risk of fatal coronary heart disease associated with diabetes in
men and women: meta-analysis of 37 prospective cohort studies. BMJ.
332:73–78. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Alzahrani SH, Hess K, Price JF, et al:
Gender-specific alterations in fibrin structure function in type 2
diabetes: associations with cardiometabolic and vascular markers. J
Clin Endocrinol Metab. 97:E2282–E2287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dekker LH, Nicolaou M, van der ADL, et al:
Sex differences in the association between serum ferritin and
fasting glucose in type 2 diabetes among South Asian Surinamese,
African Surinamese, and ethnic Dutch: the population-based SUNSET
study. Diabetes Care. 36:965–971. 2013. View Article : Google Scholar
|
|
39
|
Burghardt KJ, Pilsner JR, Bly MJ and
Ellingrod VL: DNA methylation in schizophrenia subjects: gender and
MTHFR 677C/T genotype differences. Epigenomics. 4:261–268. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zoppini G, Negri C, Stoico V, Casati S,
Pichiri I and Bonora E: Triglyceride-high-density lipoprotein
cholesterol is associated with microvascular complications in type
2 diabetes mellitus. Metabolism. 61:22–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Henderson SR, Maitland R, Mustafa OG,
Miell J, Crook MA and Kottegoda SR: Severe hypertriglyceridaemia in
type 2 diabetes mellitus: beneficial effect of continuous insulin
infusion. QJM. 106:355–359. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kulis M, Queiros AC, Beekman R and
Martin-Subero JI: Intragenic DNA methylation in transcriptional
regulation, normal differentiation and cancer. Biochim Biophys
Acta. 1829:1161–1174. 2013. View Article : Google Scholar : PubMed/NCBI
|
